Clinical

Artificial Intelligence-based agents in chronic liver disease: transforming diagnostic and therapeutic workflows through clinical decision-making

Chronic liver diseases encompass a complex continuum spanning metabolic dysfunction-associated steatotic liver disease (MASLD), steatohepatitis (MASH), alcohol-related liver disease (ALD),...

Our first guideline on kidney cancer recommends better use of biopsies to avoid surgery | National Institute for Health and Clinical Excellence (NICE)

New guidance aims to reduce variation in treatment and prevent unnecessary surgery, improving care for patients and supporting healthcare professionals....

Fresenius Medical Care’s Third-Party Clinical Research Organization Frenova Announces Strategic Collaboration Advancing Genomics-Driven, Precision Kidney Disease Care

Frenova and Nephronomics, a renal precision company co-founded by Fresenius Medical Care, initiate collaboration with GENEWIZ by Azenta Life Sciences...

Fresenius Medical Care’s Third-Party Clinical Research Organization Frenova Announces Strategic Collaboration Advancing Genomics-Driven, Precision Kidney Disease Care

Frenova and Nephronomics, a renal precision company co-founded by Fresenius Medical Care, initiate collaboration with GENEWIZ by Azenta Life Sciences...